Image by Tonyç via Flickr
So, why do some continue to fool around with IR [Immediate Release] meds? - Money talks, their money.
See the 7 Tips on how to understand better IR titration strategies, soon at EzineArticles.com
Managed Care Creates A Significant Problem, Cost is a Problem, but IR medications create even downstream challenges that often lead to treatment failure and non compliance:
With
the increased influence of managed care, the choices of medications for
thousands are limited to the generic [often less expensive] immediate
release medications. IR medications are less than satisfactory in the
first place, for reasons listed below.
Ineffective treatment
incurs greater long term costs on many levels. Why managed care would
encourage the use of less medically effective products and create
greater cost, coupled with that inferior patient care, is a challenging
subject beyond the scope of this brief overview.
Clinical Implications of IR Medications
On
first thought, one might guess that the IR medications would almost
always be adjusted correctly, as they have been around for decades, and
appear at first as more simple, less complex intervention strategies.
The
most difficult aspect of this unhappy circumstance: IR choices with stimulant medications regularly seem to invite insufficient attention
to adequate adjustment. Indeed they are often adjusted incorrectly.
Watch for this next article should be approved soon, ...isn't Grumpy, but applies to many folks using the IR dosing strategies for stimulant meds.
So, why do some continue to fool around with IR [Immediate Release] meds? - Money talks, their money.
See the 7 Tips on how to understand better IR titration strategies, soon at EzineArticles.com
Managed Care Creates A Significant Problem, Cost is a Problem, but IR medications create even downstream challenges that often lead to treatment failure and non compliance:
With the increased influence of managed care, the choices of medications for thousands are limited to the generic [often less expensive] immediate release medications. IR medications are less than satisfactory in the first place, for reasons listed below.
Ineffective treatment incurs greater long term costs on many levels. Why managed care would encourage the use of less medically effective products and create greater cost, coupled with that inferior patient care, is a challenging subject beyond the scope of this brief overview.
Clinical Implications of IR Medications
On first thought, one might guess that the IR medications would almost always be adjusted correctly, as they have been around for decades, and appear at first as more simple, less complex intervention strategies.
The most difficult aspect of this unhappy circumstance: IR choices with stimulant medications regularly seem to invite insufficient attention to adequate adjustment. Indeed they are often adjusted incorrectly.
Watch for this next article should be approved soon, ...isn't Grumpy, but applies to many folks using the IR dosing strategies for stimulant meds.